CN108837843A - A kind of Bimetallic Zeolite Catalyst and its preparation and application - Google Patents
A kind of Bimetallic Zeolite Catalyst and its preparation and application Download PDFInfo
- Publication number
- CN108837843A CN108837843A CN201810670841.1A CN201810670841A CN108837843A CN 108837843 A CN108837843 A CN 108837843A CN 201810670841 A CN201810670841 A CN 201810670841A CN 108837843 A CN108837843 A CN 108837843A
- Authority
- CN
- China
- Prior art keywords
- catalyst
- zeolite catalyst
- metal
- preparation
- bimetallic zeolite
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003054 catalyst Substances 0.000 title claims abstract description 88
- 229910021536 Zeolite Inorganic materials 0.000 title claims abstract description 21
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 title claims abstract description 21
- 239000010457 zeolite Substances 0.000 title claims abstract description 21
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- 239000002184 metal Substances 0.000 claims abstract description 16
- 229910052751 metal Inorganic materials 0.000 claims abstract description 16
- 239000002808 molecular sieve Substances 0.000 claims abstract description 7
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 claims abstract description 7
- 229910052759 nickel Inorganic materials 0.000 claims abstract description 5
- FFGPTBGBLSHEPO-UHFFFAOYSA-N carbamazepine Chemical compound C1=CC2=CC=CC=C2N(C(=O)N)C2=CC=CC=C21 FFGPTBGBLSHEPO-UHFFFAOYSA-N 0.000 claims description 34
- 229960000623 carbamazepine Drugs 0.000 claims description 34
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical group [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 claims description 30
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 20
- 239000002351 wastewater Substances 0.000 claims description 19
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 13
- 230000001590 oxidative effect Effects 0.000 claims description 12
- 238000006243 chemical reaction Methods 0.000 claims description 11
- 239000007800 oxidant agent Substances 0.000 claims description 11
- 239000011148 porous material Substances 0.000 claims description 10
- 238000007254 oxidation reaction Methods 0.000 claims description 9
- BOTDANWDWHJENH-UHFFFAOYSA-N Tetraethyl orthosilicate Chemical compound CCO[Si](OCC)(OCC)OCC BOTDANWDWHJENH-UHFFFAOYSA-N 0.000 claims description 8
- 238000002425 crystallisation Methods 0.000 claims description 8
- 230000008025 crystallization Effects 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 230000003647 oxidation Effects 0.000 claims description 7
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 6
- 238000001027 hydrothermal synthesis Methods 0.000 claims description 6
- 150000003839 salts Chemical class 0.000 claims description 6
- 229910052710 silicon Inorganic materials 0.000 claims description 6
- 239000010703 silicon Substances 0.000 claims description 6
- 238000005406 washing Methods 0.000 claims description 5
- 238000001354 calcination Methods 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 3
- 238000012545 processing Methods 0.000 claims description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 2
- 239000004115 Sodium Silicate Substances 0.000 claims description 2
- 239000000460 chlorine Substances 0.000 claims description 2
- 229910052801 chlorine Inorganic materials 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims description 2
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 claims description 2
- 150000002739 metals Chemical class 0.000 claims description 2
- 235000019795 sodium metasilicate Nutrition 0.000 claims description 2
- NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical group [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 claims description 2
- 229910052911 sodium silicate Inorganic materials 0.000 claims description 2
- 238000010792 warming Methods 0.000 claims description 2
- XTEGARKTQYYJKE-UHFFFAOYSA-M Chlorate Chemical compound [O-]Cl(=O)=O XTEGARKTQYYJKE-UHFFFAOYSA-M 0.000 claims 2
- 239000000126 substance Substances 0.000 abstract description 4
- 229910044991 metal oxide Inorganic materials 0.000 abstract description 3
- 150000004706 metal oxides Chemical class 0.000 abstract description 3
- 229910021645 metal ion Inorganic materials 0.000 abstract description 2
- 238000012546 transfer Methods 0.000 abstract description 2
- 239000007789 gas Substances 0.000 description 16
- 230000000694 effects Effects 0.000 description 11
- 238000003756 stirring Methods 0.000 description 10
- PXHVJJICTQNCMI-UHFFFAOYSA-N nickel Substances [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 230000003197 catalytic effect Effects 0.000 description 7
- 229910002651 NO3 Inorganic materials 0.000 description 5
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 5
- 238000004090 dissolution Methods 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 239000003344 environmental pollutant Substances 0.000 description 4
- 231100000719 pollutant Toxicity 0.000 description 4
- 238000004438 BET method Methods 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 230000003556 anti-epileptic effect Effects 0.000 description 2
- 239000001961 anticonvulsive agent Substances 0.000 description 2
- 230000006793 arrhythmia Effects 0.000 description 2
- 206010003119 arrhythmia Diseases 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000003651 drinking water Substances 0.000 description 2
- 235000020188 drinking water Nutrition 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- -1 hydroxyl radical free radical Chemical class 0.000 description 2
- WQYVRQLZKVEZGA-UHFFFAOYSA-N hypochlorite Chemical compound Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 239000010865 sewage Substances 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- MQRWBMAEBQOWAF-UHFFFAOYSA-N acetic acid;nickel Chemical compound [Ni].CC(O)=O.CC(O)=O MQRWBMAEBQOWAF-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000003741 agents affecting lipid metabolism Substances 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229940046836 anti-estrogen Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000003907 antipyretic analgesic agent Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 229960000074 biopharmaceutical Drugs 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 239000002872 contrast media Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 239000000328 estrogen antagonist Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl Chemical compound [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229940078494 nickel acetate Drugs 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 150000003891 oxalate salts Chemical class 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 238000006385 ozonation reaction Methods 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 239000010802 sludge Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000002352 surface water Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000003204 tranquilizing agent Substances 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J29/00—Catalysts comprising molecular sieves
- B01J29/03—Catalysts comprising molecular sieves not having base-exchange properties
- B01J29/0308—Mesoporous materials not having base exchange properties, e.g. Si-MCM-41
- B01J29/0341—Mesoporous materials not having base exchange properties, e.g. Si-MCM-41 containing arsenic, antimony, bismuth, vanadium, niobium, tantalum, polonium, chromium, molybdenum, tungsten, manganese, technetium or rhenium
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J29/00—Catalysts comprising molecular sieves
- B01J29/03—Catalysts comprising molecular sieves not having base-exchange properties
- B01J29/0308—Mesoporous materials not having base exchange properties, e.g. Si-MCM-41
- B01J29/0316—Mesoporous materials not having base exchange properties, e.g. Si-MCM-41 containing iron group metals, noble metals or copper
- B01J29/0333—Iron group metals or copper
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/72—Treatment of water, waste water, or sewage by oxidation
- C02F1/725—Treatment of water, waste water, or sewage by oxidation by catalytic oxidation
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/72—Treatment of water, waste water, or sewage by oxidation
- C02F1/78—Treatment of water, waste water, or sewage by oxidation with ozone
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2229/00—Aspects of molecular sieve catalysts not covered by B01J29/00
- B01J2229/10—After treatment, characterised by the effect to be obtained
- B01J2229/18—After treatment, characterised by the effect to be obtained to introduce other elements into or onto the molecular sieve itself
- B01J2229/186—After treatment, characterised by the effect to be obtained to introduce other elements into or onto the molecular sieve itself not in framework positions
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2101/00—Nature of the contaminant
- C02F2101/30—Organic compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hydrology & Water Resources (AREA)
- Environmental & Geological Engineering (AREA)
- Water Supply & Treatment (AREA)
- Dispersion Chemistry (AREA)
- Materials Engineering (AREA)
- Catalysts (AREA)
- Exhaust Gas Treatment By Means Of Catalyst (AREA)
Abstract
The present invention proposes a kind of Bimetallic Zeolite Catalyst, is two kinds in Mn, Ce, Co, Ni of the metal with two kinds of metal-modified KIT-6 molecular sieve catalysts, and the molar ratio of Si and each modified metal is 10~60 independently of each other.The present invention also proposes the preparation method and application of the Bimetallic Zeolite Catalyst.Compared with traditional supported catalysts, metal oxide enters in skeleton the present invention, be combined with each other more secured, metal ion is not easy to dissolve out, catalyst performance stabilised.Metallic molecule sieve catalyst prepared by the present invention has unique three-dimensional cubic duct, and hole wall thickness, aperture is big, duct is mutually communicated and the orderly opening substance that is conducive to is spread, and reduces internal mass transfer resistance, is not easy to plug duct.
Description
Technical field
The invention belongs to catalyst technical fields, and in particular to a kind of catalyst and its preparation with metal-modified modification
And application.
Background technique
PPCPs refers to drug and personal care product, the representative species in the waste water containing PPCPs have antimicrobial,
Antipyretic analgesic anti-inflammatory drug, estrogen and other drugs (such as lipid regulating agent, antiepileptic, tranquillizer, contrast agent) and makeup
Common fragrance in product.Carbamazepine has wide spectrum drug effect, is not only the choice drug of anti-epileptic, is also usually utilized to treatment suppression
The diseases such as strongly fragrant, arrhythmia cordis are widely used because its drug effect is significant.Carbamazepine is entered by pharmaceutical factory waste water and body metabolism
Environment detects the presence of carbamazepine in sewage treatment plant, surface water even drinking water.As research finds Karma
Xiping also has some side effects such as nausea and vomiting, food while having good therapeutic effect to diseases such as epilepsy, depression, arrhythmia cordis
It is intended to change, dysfunction of liver and skin lesion etc., has become one of PPCPs pollutant of greatest concern at present.Research
Personnel point out that this kind of drug is relatively stable, are difficult during sewage treatment and drinking water treatment raw by activated sludge and film
The standard biologics method for treating water such as object reactor is effectively removed.
Ozone is as a kind of novel green clean oxidation technology, because it is with strong oxidizing property and disinfecting power, in water
Process field is widely used.But since independent ozone exists to pollutant oxidation with selective, ozone utilization rate is low, is difficult to
The defects of thorough mineralising pollutant, is restricted the application of this technology to a certain extent.Catalytic ozonation is
Ozone molecule is promoted to decompose the generation stronger hydroxyl radical free radical isoreactivity intermediate of oxidisability using catalyst to strengthen ozone oxygen
Change ability, the hydroxyl radical free radical oxidability that catalysis ozone generates are stronger and to pollutant non-selectivity.O3 catalytic oxidation skill
The key of art is the research and development and preparation of high activated catalyst.
Mesostructured material, SBA-15, KIT-6 etc. are due to specific surface area is high, cellular structure is orderly, hydro-thermal is steady
The advantages that qualitative high, is widely used in absorption, separation and catalytic field.Compared to MCM-41 and SBA-15, KIT-6 has only
Special three-dimensional cubic duct, hole wall thickness, aperture is big, duct is mutually communicated and the orderly opening substance that is conducive to is spread, and reduces internal
Resistance to mass tranfer is not easy to plug duct.But pure KIT-6 is neutral backbone and active site is few.
Summary of the invention
For shortcoming existing for this field, an object of the present invention is to propose a kind of bimetallic molecular sieve catalytic
Agent.
Second object of the present invention is to propose the preparation method of the Bimetallic Zeolite Catalyst.
Third object of the present invention is to propose the application of the Bimetallic Zeolite Catalyst.
The technical solution for realizing above-mentioned purpose of the present invention is:
A kind of Bimetallic Zeolite Catalyst is with two kinds of metal-modified KIT-6 molecular sieve catalysts, the metal choosing
From two kinds in Mn, Ce, Co, Ni, the molar ratio of Si and each modified metal is 10~60 independently of each other.
Pure KIT-6 is neutral backbone and active site is few.Because Mn, Ce, Co, Ni metal oxide have a variety of valence states, tool
There is good redox ability, selects Mn, Ce, Co, Ni to be modified KIT-6, improve the catalytic capability of KIT-6.
Preferably, the Bimetallic Zeolite Catalyst specific surface area is 600~800m2/ g, average pore size be 2~
10nm, total pore volume are 0.5~2.0cm3/g。
It is highly preferred that two kinds of metals are selected from one of the following group:Mn and Ni, Ce and Co, Mn and Co;Si and each
The molar ratio of modified metal is:Si/Mn=Si/Ni=15~25, Si/Ce=Si/Co=15~25, Si/Mn=Si/Co=20
~60.
The preparation method of Bimetallic Zeolite Catalyst of the present invention, including operation:
Template, n-butanol, silicon source, metal salt, which are dissolved in acid solution, is made mixture, at 20~60 DEG C react 20~
30h;
Crystallization is carried out at 95~110 DEG C;
In 500~600 DEG C of temperature lower calcinations.
The metal salt can be selected from nitrate, acetate, sulfate, hydrochloride, oxalates, the phosphoric acid of the modified metal
One of salt.
Wherein, the template is P123, the silicon source is sodium metasilicate or ethyl orthosilicate, sour dense in the acid solution
Degree is 0.1~2mol/L.
Wherein, the template, n-butanol, silicon source mass ratio be (4~6):(4~6):(10~12), template
The mass volume ratio example that acid solution is added is 5g:(100~200) mL.
Wherein, 500~600 DEG C are warming up to 1~3 DEG C of heating rate to be calcined.
A preferred technical solution of the present invention is that the preparation method includes step:
(1) by P123It is dissolved in the hydrochloric acid solution that concentration is 0.1~1mol/L;
(2) n-butanol is added into solution, is stirred under the conditions of 30~40 DEG C of temperature;
(3) ethyl orthosilicate and two kinds of metal salts are added, is dissolved in dilute hydrochloric acid solution and forms mixture, at 30~40 DEG C
It is stirred to react under the conditions of temperature 20~30 hours;
(4) step (3) acquired solution is put into hydrothermal reaction kettle, control 95~110 DEG C of reaction crystallization 20~30 of temperature are small
When, crystallized product is filtered, washed;
(5) product after washing is dry at 80~150 DEG C;
(6) product is in 500~600 DEG C of 5~8h of temperature lower calcination after drying.
Application of the Bimetallic Zeolite Catalyst in the processing of the water containing PPCPs.
Further, handled water be in contain carbamazepine, carry out oxidation processes with oxidant, the oxidant is
One of ozone, chlorine, hypochlorous acid, hypochlorite are a variety of;The pH value of the waste water is 2~9;The bimetallic molecular sieve
The dosage of catalyst is 0.1~5g/L.
Another optimal technical scheme of the invention is to carry out oxidation processes with ozone, the pH value of the waste water is 2~9;
Catalyst uses disposable dosing method, and by the way of continuously adding, the Bimetallic Zeolite Catalyst adds ozone
Amount is 1~3g/L.The haptoreaction time of ozone, Bimetallic Zeolite Catalyst and waste water is 1~30min.
Compared with prior art, Bimetallic Zeolite Catalyst of the present invention has the following advantages that:
(1) compared with traditional supported catalysts, metal oxide enters in skeleton the present invention, be combined with each other more firm
Gu metal ion is not easy to dissolve out, catalyst performance stabilised.(2) metallic molecule sieve catalyst prepared by the present invention has unique three
Cube duct is tieed up, hole wall thickness, aperture is big, duct is mutually communicated and the orderly opening substance that is conducive to is spread, and reduces internal mass transfer resistance
Power is not easy to plug duct.(3) metallic molecule sieve catalyst large specific surface area prepared by the present invention, hydrothermal stability height, active group
Divide dispersion degree high, there is certain enrichment to Organic substance in water, pass through surface enrichment organic matter and ozone and promotes ozone
It decomposes and generates more hydroxyl radical free radicals to improve oxidation rate.
Metallic molecule sieve catalyst Mn-Co-KIT-6 effectively increases the efficiency of ozone removal carbamazepine.2.5 points of reaction
Zhong Shi, O3Removal rate to carbamazepine is 25.9%, and catalyst Mn-Co-KIT-6 (Si/Mn=Si/Co=20) is to Karma
The removal rate in Xiping is then up to 66%, purer O3Improve 40.1%;O at 10 minutes3Removal rate to carbamazepine is
77.8%, Mn-Co-KIT-6 (Si/Mn=Si/Co=20) are 88.4%, purer O3Improve 10.6%.
Detailed description of the invention
Fig. 1 is the XRD diagram of catalyst Mn-Co-KIT-6 (Si/Mn=Si/Co=20) prepared by embodiment 4.
Fig. 2 is the pure O of embodiment 13With embodiment 2, embodiment 3, embodiment 4 prepare catalyst and carbamazepine is gone
Except efficiency chart.
Fig. 3 is the industrial catalyst of catalyst, embodiment 5 and the purchase of embodiment 6 prepared by embodiment 4 to carbamazepine
Removal efficiency figure.
Fig. 4 is removal efficiency figure of the catalyst to carbamazepine of embodiment 4, embodiment 7 and the preparation of embodiment 8.
Fig. 5 be embodiment 4 prepare catalyst in the simulated wastewater of different pH value to the removal efficiency figure of carbamazepine.
Specific embodiment
The present invention is now illustrated with following embodiment, but is not limited to the scope of the present invention.
Means used in embodiment use the means of this field routine unless otherwise instructed.
Embodiment 1:
O3Oxidation test:Simulated wastewater is that (natural ph of waste water is 20mg/L carbamazepine solution 1L when not adjusting pH
6.5) it, is continuously added using ozone as oxidant, gas flow rate 0.25L/min, O3Gas phase concentration 2mg/L.
2~5min sample detection is spaced in 0~15min of haptoreaction time of ozone, molecular sieve catalyst and waste water.
When reacting 2.5 minutes, O3Removal rate to carbamazepine reached for 77.8% (referring to fig. 2) when being 25.9%, 10 minutes.
Embodiment 2:
Catalyst preparation:
5gP123It is dissolved in the dilute hydrochloric acid solution that 175mL concentration is 0.5mol/L, stirs 1h;
5g n-butanol is added, stirs 1h under the conditions of 35 DEG C of water-bath;10.75g ethyl orthosilicate is added, after Si/ in molar ratio
Mn (the NO that 0.634g nickel acetate and 0.93g mass fraction are 50% by Mn=Si/Ni=203)2·4H2Solution dissolution is added in O,
It is stirred for 24 hours under the conditions of 35 DEG C of water-bath;
Solution is put into hydrothermal reaction kettle crystallization in 100 DEG C of baking ovens later and for 24 hours, it is natural to take out reaction kettle after reaction
It is cooled to room temperature, filters, washing.
Obtained product is dried into 6h in 100 DEG C of baking ovens, calcines 6h, the liter of Muffle furnace in 550 DEG C of Muffle furnaces later
Warm rate is 2 DEG C/min, obtains catalyst Mn-Ni-KIT-6 (Si/Mn=Si/Ni=20).It is detected with BET method, gained molecule
The specific surface area of sieve catalyst is 693.1m2/ g, average pore size 5.93nm, total pore volume 1.03cm3/g。
Catalyst activity test:
Simulated wastewater is 20mg/L carbamazepine solution 1L, is continuously added using ozone as oxidant, gas flow rate is
0.25L/min, O3Gas phase concentration 2mg/L, catalyst amount 2g.
When reacting 2.5 minutes, catalyst Mn-Ni-KIT-6 (Si/Mn=Si/Ni=20) is to the removal rate of carbamazepine
Reached for 77.5% (referring to fig. 2) when 44.7%, 10 minutes.
Embodiment 3:
Catalyst preparation:
5g P123It is dissolved in the dilute hydrochloric acid solution that 175mL concentration is 0.5mol/L, stirs 1h;5g n-butanol, water-bath 35 is added
1h is stirred under the conditions of DEG C;10.75g ethyl orthosilicate is added, after in molar ratio Si/Ce=Si/Co=20 by 0.75gCo
(NO3)2·6H2O and 1.12gCe (NO3)2·6H2Solution dissolution is added in O, stirs for 24 hours under the conditions of 35 DEG C of water-bath;Later by solution
It is put into hydrothermal reaction kettle crystallization in 100 DEG C of baking ovens and for 24 hours, takes out reaction kettle cooled to room temperature after reaction, filter, wash
It washs.
Obtained product is dried into 6h in 100 DEG C of baking ovens, calcines 6h, Muffle furnace heating in 550 DEG C of Muffle furnaces later
Rate is 2 DEG C/min, obtains catalyst Ce-Co-KIT-6 (Si/Ce=Si/Co=20).It is detected with BET method, gained molecular sieve
The specific surface area 742m of catalyst2/ g, average pore size 6.51nm, total pore volume 1.21cm3/g。
Catalyst activity test:
Simulated wastewater is 20mg/L carbamazepine solution 1L, is continuously added using ozone as oxidant, gas flow rate is
0.25L/min, O3Gas phase concentration 2mg/L, catalyst amount 2g.When reacting 2.5 minutes, catalyst Ce-Co-KIT-6 (Si/Ce
=Si/Co=20) to reaching for 83.7% (referring to fig. 2) when the removal rate of carbamazepine is 41%, 10 minutes.
Embodiment 4:
Catalyst preparation:
5gP123It is dissolved in the dilute hydrochloric acid solution that 175mL concentration is 0.5mol/L, stirs 1h;Addition 5g n-butanol, 35 DEG C of water-bath
Under the conditions of stir 1h;10.75g ethyl orthosilicate is added, after in molar ratio Si/Mn=Si/Co=20 by 0.75gCo (NO3)2·
6H2Mn (the NO that O and 0.93g mass fraction is 50%3)2·4H2Solution dissolution is added in O, stirs for 24 hours under the conditions of 35 DEG C of water-bath;It
Solution hydrothermal reaction kettle crystallization in 100 DEG C of baking ovens is put into afterwards for 24 hours, to take out reaction kettle after reaction and naturally cool to room
Temperature filters, washing.
Obtained product is dried into 6h in 100 DEG C of baking ovens, calcines 6h, the liter of Muffle furnace in 550 DEG C of Muffle furnaces later
Warm rate is 2 DEG C/min, obtains catalyst Mn-Co-KIT-6 (Si/Mn=Si/Co=20).It is detected with BET method, gained molecule
The specific surface area of sieve catalyst is 713.8m2/ g, average pore size 6.02nm, total pore volume 1.07cm3/g。
Fig. 1 is the XRD spectrum of Mn-Co-KIT-6 (Si/Mn=Si/Co=20).XRD diagram shows catalyst Mn-Co-KIT-
6 (Si/Mn=Si/Co=20) tool shows that the catalyst has the three-dimensional of high-sequential vertical there are three apparent characteristic diffraction peak
Square duct.
Catalyst activity test:Simulated wastewater is 20mg/L carbamazepine solution 1L, is continuously added using ozone as oxidant,
Gas flow rate is 0.25L/min, O3Gas phase concentration 2mg/L, catalyst amount 2g.When reacting 2.5 minutes, catalyst Mn-Co-
KIT-6 (Si/Mn=Si/Co=20) reaches 88.4% (referring to figure when being up to 66%, 10 minutes to the removal rate of carbamazepine
2).Compared with Mn-Ni-KIT-6 (Si/Mn=Si/Ni=20) and Ce-Co-KIT-6 (Si/Ce=Si/Co=20), Mn-Co-
The catalytic activity of KIT-6 (Si/Mn=Si/Co=20) is higher, and it is final catalyst that Mn-Co-KIT-6 is selected in research later.
Embodiment 5:
Catalyst activity test:Commercial ozone catalyst 1 and commercial ozone catalyst 2 are ground to powder, take 2g respectively
For reacting, simulated wastewater is 20mg/L carbamazepine solution 1L, and oxidant is ozone, gas flow rate 0.25L/min, O3Gas
Phase concentration 2mg/L.
When reacting 2.5 minutes, commercial ozone catalyst 1 is 23% to the removal rate of carbamazepine, commercial ozone catalyst 2
Removal rate to carbamazepine is 32.5%.Commercialization ozone catalyst 1 reaches 77% to the removal rate of carbamazepine at 10 minutes,
Commercial ozone catalyst 2 reaches 80% (referring to Fig. 3) to the removal rate of carbamazepine.With pure O3Oxidation is compared, and commercial ozone is urged
Agent 1 is to the removal of carbamazepine without facilitation, and commercial ozone catalyst 2 has certain promotion to the removal of carbamazepine
Effect, but facilitation is significantly less than the facilitation of Mn-Co-KIT-6 (Si/Mn=Si/Co=20).
Embodiment 6:
Catalyst preparation:
5gP123It is dissolved in the dilute hydrochloric acid solution that 175mL concentration is 0.5mol/L, stirs 1h;Addition 5g n-butanol, 35 DEG C of water-bath
Under the conditions of stir 1h;10.75g ethyl orthosilicate is added, after in molar ratio Si/Mn=Si/Co=40 by 0.376gCo (NO3)2·
6H2Mn (the NO that O and 0.462g mass fraction is 50%3)2·4H2Solution dissolution is added in O, stirs for 24 hours under the conditions of 35 DEG C of water-bath;
Solution hydrothermal reaction kettle crystallization in 100 DEG C of baking ovens is put into later for 24 hours, to take out reaction kettle after reaction and naturally cool to room
Temperature filters, washing.
Obtained product is dried into 6h in 100 DEG C of baking ovens, calcines 6h, the liter of Muffle furnace in 550 DEG C of Muffle furnaces later
Warm rate is 2 DEG C/min, obtains catalyst Mn-Co-KIT-6 (Si/Mn=Si/Co=40), and Mn-Co-KIT-6 is similarly made
(Si/Mn=Si/Co=60).
Catalyst activity test:
Simulated wastewater is 20mg/L carbamazepine solution 1L, is continuously added using ozone as oxidant, gas flow rate is
0.25L/min, O3Gas phase concentration 2mg/L, catalyst amount 2g.
Referring to fig. 4, when reacting 2.5 minutes, catalyst Mn-Co-KIT-6 (Si/Mn=Si/Co=40) is to carbamazepine
Removal rate reaches 86.5% when being 61.1%, 10 minutes;When reacting 2.5 minutes, catalyst Mn-Co-KIT-6 (Si/Mn=Si/
Co=60) to the removal rate of carbamazepine be 58.9%, 10 minutes when reach 84.9%.
Embodiment 7:
Catalyst activity test:Simulated wastewater is 20mg/L carbamazepine solution 1L, with hydrochloric acid by the pH tune of simulated wastewater
It is 3, is continuously added using ozone as oxidant, gas flow rate 0.25L/min, O3Gas phase concentration 2mg/L, catalyst Mn-Co-
KIT-6 (Si/Mn=Si/Co=20) dosage 2g.When reacting 2.5 minutes, catalyst Mn-Co-KIT-6 (Si/Mn=Si/Co=
20) to the removal rate of carbamazepine be 61%, 10 minutes when reach 91.1%, show acidic environment to Mn-Co-KIT-6 (Si/
Mn=Si/Co=20 activity) has slight facilitation without influence instead (referring to Fig. 5).
Embodiment 8:
Catalyst activity test:Simulated wastewater is 20mg/L carbamazepine solution 1L, with sodium hydroxide solution that simulation is useless
The pH of water is adjusted to 9, gas flow rate 0.25L/min, O3Gas phase concentration 2mg/L, catalyst Mn-Co-KIT-6 (Si/Mn=Si/
Co=20) dosage 2g.When reacting 2.5 minutes, catalyst Mn-Co-KIT-6 (Si/Mn=Si/Co=20) removes carbamazepine
Except rate be 51.5%, 10 minutes when reach 84%, show the alkaline environment to Mn-Co-KIT-6's (Si/Mn=Si/Co=20)
Activity has slight inhibiting effect (referring to Fig. 5).
By embodiment 7-8 it is found that the metallic molecule sieve catalyst has well in the wider pH application range 3-9 of solution
Catalytic activity, the scope of application is wider.
Above embodiment be only preferred embodiments of the present invention will be described, not to the scope of the present invention into
Row limits, and without departing from the spirit of the design of the present invention, this field ordinary engineering and technical personnel is to technical side of the invention
The all variations and modifications that case is made, should fall within the scope of protection determined by the claims of the present invention.
Claims (10)
1. a kind of Bimetallic Zeolite Catalyst, which is characterized in that be with two kinds of metal-modified KIT-6 molecular sieve catalysts,
The molar ratio of two kinds in Mn, Ce, Co, Ni of the metal, Si and each modified metal is 10~60 independently of each other.
2. Bimetallic Zeolite Catalyst according to claim 1, which is characterized in that the Bimetallic Zeolite Catalyst
Specific surface area is 600~800m2/ g, average pore size are 2~10nm, and total pore volume is 0.5~2.0cm3/g。
3. Bimetallic Zeolite Catalyst according to claim 1 or 2, which is characterized in that two kinds of metals are selected from
With one of the following group:Mn and Ni, Ce and Co, Mn and Co;The molar ratio of Si and each modified metal is:Si/Mn=Si/Ni=15
~25, Si/Ce=Si/Co=15~25, Si/Mn=Si/Co=20~60.
4. the preparation method of the described in any item Bimetallic Zeolite Catalysts of claims 1 to 3, which is characterized in that including behaviour
Make:
Template, n-butanol, silicon source, metal salt, which are dissolved in acid solution, is made mixture, and 20~30h is reacted at 20~60 DEG C;
Crystallization is carried out at 95~110 DEG C;
In 500~600 DEG C of temperature lower calcinations.
5. the preparation method according to claim 4, which is characterized in that the template is P123, the silicon source is sodium metasilicate
Or ethyl orthosilicate, sour concentration is 0.1~2mol/L in the acid solution.
6. the preparation method according to claim 4, which is characterized in that the template, n-butanol, silicon source mass ratio
For (4~6):(4~6):(10~12), the mass volume ratio example that acid solution is added in template is 5g:(100~200) mL.
7. the preparation method according to claim 4, which is characterized in that be warming up to 500~600 with 1~3 DEG C of heating rate
It DEG C is calcined.
8. the preparation method according to claim 4, which is characterized in that including step:
(1) by P123It is dissolved in the hydrochloric acid solution that concentration is 0.1~1mol/L;
(2) n-butanol is added into solution, is stirred under the conditions of 30~40 DEG C of temperature;
(3) ethyl orthosilicate and two kinds of metal salts are added, is dissolved in dilute hydrochloric acid solution and forms mixture, in 30~40 DEG C of temperature
Under the conditions of be stirred to react 20~30 hours;
(4) step (3) acquired solution is put into hydrothermal reaction kettle, controls reaction crystallization 20~30 hours of 95~110 DEG C of temperature, it will
Crystallized product is filtered, washed;
(5) product after washing is dry at 80~150 DEG C;
(6) product is in 500~600 DEG C of 5~8h of temperature lower calcination after drying.
9. application of any one of claims 1 to 3 Bimetallic Zeolite Catalyst in the processing of the water containing PPCPs.
10. the method for any one of the application claims 1 to 3 Bimetallic Zeolite Catalyst processing waste water, which is characterized in that
Contain carbamazepine in handled water, carry out oxidation processes with oxidant, the oxidant is ozone, chlorine, hypochlorous acid, secondary
One of chlorate is a variety of;The pH value of the waste water is 2~9;The dosage of the Bimetallic Zeolite Catalyst is 0.1
~5g/L.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810670841.1A CN108837843B (en) | 2018-06-26 | 2018-06-26 | Bimetallic molecular sieve catalyst and preparation and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810670841.1A CN108837843B (en) | 2018-06-26 | 2018-06-26 | Bimetallic molecular sieve catalyst and preparation and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108837843A true CN108837843A (en) | 2018-11-20 |
CN108837843B CN108837843B (en) | 2021-01-26 |
Family
ID=64202429
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810670841.1A Active CN108837843B (en) | 2018-06-26 | 2018-06-26 | Bimetallic molecular sieve catalyst and preparation and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108837843B (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112316972A (en) * | 2020-10-16 | 2021-02-05 | 河北莫兰斯环境科技股份有限公司 | Preparation method and application of mesoporous-microporous ZSM-5-based ozone catalyst |
CN115254176A (en) * | 2022-07-17 | 2022-11-01 | 江苏科技大学 | Nano-zeolite-coated heavy metal cluster catalytic wet oxidation catalyst and preparation method and application thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105435829A (en) * | 2015-11-11 | 2016-03-30 | 华南师范大学 | Preparation method and application of Co-Mn-MCM-41 molecular sieve |
-
2018
- 2018-06-26 CN CN201810670841.1A patent/CN108837843B/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105435829A (en) * | 2015-11-11 | 2016-03-30 | 华南师范大学 | Preparation method and application of Co-Mn-MCM-41 molecular sieve |
Non-Patent Citations (2)
Title |
---|
周宁娟等: "ZnOOH催化臭氧氧化去除水中痕量卡马西平", 《中国给水排水》 * |
高兰君等: "Ce-Co/KIT-6介孔材料的制备及其脱汞性能的研究", 《燃料化学学报》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112316972A (en) * | 2020-10-16 | 2021-02-05 | 河北莫兰斯环境科技股份有限公司 | Preparation method and application of mesoporous-microporous ZSM-5-based ozone catalyst |
CN115254176A (en) * | 2022-07-17 | 2022-11-01 | 江苏科技大学 | Nano-zeolite-coated heavy metal cluster catalytic wet oxidation catalyst and preparation method and application thereof |
CN115254176B (en) * | 2022-07-17 | 2024-03-15 | 江苏科技大学 | Nano zeolite coated heavy metal cluster catalytic wet oxidation catalyst and preparation method and application thereof |
Also Published As
Publication number | Publication date |
---|---|
CN108837843B (en) | 2021-01-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102219498B (en) | Water purification ceramic material and preparation method thereof | |
CN108380235A (en) | A kind of preparation method and applications of the heterogeneous class fenton catalyst of graphite phase carbon nitride base | |
CN103721677B (en) | A kind of preparation method of the biomass carbon composite for waste water dephosphorization | |
CN106215978A (en) | Organic inorganic hybridization mesoporous catalyst for purifying VOCs and preparation method thereof | |
CN104056590A (en) | Few-layer boron nitride as well as preparation method and application thereof | |
Simsek et al. | Construction of stable perovskite-type LaFeO3 particles on polymeric resin with boosted photocatalytic Fenton-like decaffeination under solar irradiation | |
CN101612560A (en) | Compound oxide photocatalyst Bi 4M 2O 11Preparation method and application thereof | |
CN108837843A (en) | A kind of Bimetallic Zeolite Catalyst and its preparation and application | |
CN105289629B (en) | UV stable agent method in a kind of lanthanum based perovskite type oxide catalyst ozone degradation water | |
CN106732509A (en) | The preparation method of modified aluminium oxide supports, catalytic ozone oxidation catalyst and its application | |
CN107140724A (en) | A kind of method that the MOFs of Co containing In absorption cooperates with Antibiotics of Low Concentration in water removal with activation persulfate | |
Peng et al. | Efficient adsorption-photocatalytic removal of tetracycline hydrochloride over La2S3-modified biochar with S, N-codoping | |
CN107175099A (en) | A kind of V ion dopings BiNb5O14Photochemical catalyst and its preparation method and application | |
CN103127933B (en) | Nano cerium oxide silver-loaded catalyst, manufacturing method and purpose thereof | |
JP2016209811A (en) | Photocatalyst composite material and manufacturing method thereof | |
CN111841606B (en) | Heterogeneous FeVO4Catalytic material, preparation method and application thereof | |
CN105618050A (en) | Visible-light responded compound catalyst for degrading organic pollutants in salt-containing wastewater and preparation method of visible-light responded compound catalyst | |
CN106238084A (en) | The preparation method and application of visible ray synergy ozone catalytic degradation organic acid catalyst | |
CN101785860B (en) | Tegafur/layered duplex metal hydroxide nanometer hybrid and preparation method thereof | |
CN103316624B (en) | Dephosphorization agent and preparation method thereof | |
CN106925255A (en) | A kind of photochemical catalyst of room temperature catalytic decomposition formaldehyde and preparation method thereof | |
CN102718829A (en) | Method for preparing sodium tauroursodeoxycholate | |
CN106552615A (en) | The preparation method of Concave-convex clay rod composite catalyzing material | |
CN108499557A (en) | A kind of porous mangaic acid magnesium and its preparation method and application | |
Yang et al. | Enhanced photocatalytic activity of Eu2O3/Ta2O5 mixed oxides on degradation of rhodamine B and 4-nitrophenol |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220608 Address after: 215163 floor 2, building 1, No. 100, Guangqi Road, high tech Zone, Suzhou, Jiangsu Patentee after: Suzhou QingChu Environmental Technology Co.,Ltd. Address before: 100084 mailbox, 100084-82 Tsinghua Yuan, Beijing, Haidian District, Beijing Patentee before: TSINGHUA University Patentee before: Tsinghua Suzhou Environmental Innovation Research Institute |
|
TR01 | Transfer of patent right |